Extraction and visual comparison of tumour tissues
By administering the ingredients for the drug, along with the transition-metal catalyst, cancer growth was inhibited (bottom)
An international research group at the RIKEN Cluster for Pioneering Research (CPR) has successfully treated cancer in mice using metal catalysts that assemble anticancer drugs together inside the body. Published in the scientific journal Nature Communications, the study is the first report of therapeutic in vivo synthetic chemistry being used to make anticancer substances where they are needed simply by injecting their ingredients through a vein. Because this technique avoids indiscriminate tissue damage, it is expected to have a significant impact on cancer treatment.
Aside from effectiveness at killing cancer cells, a major challenge to cancer chemotherapy is how to mitigate the toxic side effects on the body. Drugs that can damage cancer cells can damage non-cancerous cells as well, and the negative side effects of chemotherapy can cause permanent and debilitating damage. Current methods for reducing these side effects include selective delivery of anticancer drugs to cancer tissue (drug delivery) and conversion of non-toxic compounds (prodrugs) into toxic compounds nearby the cancerous tissue.
Katsunori Tanaka at RIKEN CPR, who led the new study, has developed a method for activating prodrugs using transition-metal catalysis inside the body. When the catalyst is injected into an organism, it usually has no effect because it is destroyed by antioxidants such as glutathione. By placing the transition-metal catalysts inside special pockets within a protein, Tanaka and his colleagues have been able to avoid this problem and stabilize the catalytic function in vivo, thus ensuring that the chemical reaction can proceed efficiently in the body. For this technique to work, the catalyst needs to selectively find its way to the cancer. As in their previous studies, the team targeted the catalyst to the cancer by attaching chains of cancer-binding sugar molecules to the surface of the carrier protein. Using these techniques, Tanaka’s group succeeded in inhibiting cancer growth and metastasis, as well as reducing the side effects. The new study is a proof of concept in which cancer in mice was treated by actually assembling anticancer drugs inside the body near the cancer cells. “In the past, we used similar methods to attach anticancer drugs to tumors,” says Tanaka, “but here, we were able to avoid putting any toxic drugs into the body at all.”
Noting that the basic skeleton of most anticancer drugs contains a benzene ring, the researchers started by making benzene rings inside the body using transition-metal catalysts. “No one believed that artificially synthesizing benzene rings inside the body was possible, but I was confident that we could do it based on our previous achievements,” says Tanaka. Using a transition metal-catalyzed complex designed for selective delivery to cancerous tissues, they succeeded in efficiently creating the benzene-rings needed by cancer drugs in the vicinity of cancer cells. By using non-toxic substances, and only joining them together to form active anticancer drugs at the tumor site, they saw a 1000-times increase in the cancer-inhibiting activity of the drugs. Simply administering the ingredients needed for the drug, along with the transition-metal catalyst, through a vein, cancer growth was inhibited without side effects such as weight loss.
This is the first time that active anticancer drugs have been assembled on-site and effectively combatted cancer by simply injecting the ingredients for the drug through a vein. In addition to benzene, the methodology developed in this study is expected to enable a variety of other molecules to be synthesized inside the body. The hope is that this type of chemotherapy will become a useful therapeutic platform for the future of cancer treatment.
“Many patients with cancer are dying because of the side effects of treatment. We believe our technology, which attacks cancer cells highly effectively without side effects, will be able to save lives,” says Tanaka. “The method will also allow us to reconsider using compounds that have not been used before because they were too toxic when delivered to the whole body. Now they can be synthesized at the tumor site without affecting healthy tissue. We believe this is a paradigm shift for pharmaceuticals and drug discovery.”
Original Article: Cancer therapy using on-site synthesis of anticancer drugs
More from: RIKEN
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Assembling anticancer drugs inside the body
- Nanobots Market Size to Worth Around USD 21.45 Billion by 2030
The nanobot will roam throughout the body autonomously and discover cancer cells. When they are inside or engaging with the cancer cells, they will release the medicine. Anti-cancer medications ...
- Map of immune system connections reveals new therapeutic opportunities
In creating the immune system map, scientists from the Wellcome Sanger Institute, ETH Zürich, and collaborators show how immune cells across the body link ... to make assembling an accurate ...
- Killed By A Machine: The Therac-25
even deep inside the body. These room-sized medical devices would always cause some collateral damage to healthy tissue around the tumors. As with chemotherapy, the hope is that the net effect ...
- Bacterial Microrobots Deliver Drug Payload to Tumors
Scientists at the Max Planck Institute for Intelligent Systems in Germany have developed tumor-targeting microrobots using bacteria. The team exploited the tendency of bacteria to naturally gravitate ...
- Inspired by nature, artificial microtubules can work against a current to transport tiny cargoes
Inspired by biology, Arnold Mathijssen of the University of Pennsylvania and colleagues devised an artificial microtubule that can work to deliver microscopic cargo, even when operating against a ...
Go deeper with Google Headlines on:
Assembling anticancer drugs inside the body
Go deeper with Bing News on:
Negative side effects of chemotherapy
- MASTERSON ONLINE: Intro to chemo
Chemotherapy for many Arkansans, including a number of close friends, has become a reality over the years. Little wonder, since it represents a primary and effective defense against cancer.
- Why You May Want To Avoid Green Tea When Going Through Chemotherapy
Chemotherapy is very taxing on the body, and what you eat and drink is important to help you get the most from the treatment.
- FDA approves AstraZeneca, Daiichi drug in breast cancer first
Enhertu is the first targeted treatment cleared for breast cancers that are ‘HER2 low,’ a new classification that could change how doctors treat the disease.
- FDA Approves First Targeted Drug to Treat HER2 Low Breast Cancer: Trastuzumab Deruxtecan (T-DXd)
ASCO meeting, MSK medical oncologist Shanu Modi is presenting results from a clinical trial that found more people can benefit from a targeted therapy for breast cancer than previously thought.
- Advanced esophageal carcinoma: nivolumab in combination with chemotherapy or ipilimumab prolongs life in comparison with chemotherapy alone
Nivolumab has recently been approved both in combination with fluoropyrimidine- and platinum-based combination chemotherapy and in combination with ipilimumab for the first-line treatment of adults ...